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ABSTRACT
Clinical studies propose a causative link between the consumption of alcohol and 
the development and progression of liver disease in obese individuals. However, it is 
incompletely understood how alcohol and obesity interact and whether the combined 
effects are additive or synergistic. In this study, we developed an in vitro model to 
address this question. Lipid accumulation in primary human hepatocytes was induced 
by incubation with oleic acid. Subsequently, steatotic and control hepatocytes were 
incubated with up to 50 mM alcohol. This alcohol concentration on its own revealed 
only minimal effects but significantly enhanced oleate-induced lipogenesis and cellular 
triglyceride content compared to control cells. Similarly, lipid peroxidation, oxidative 
stress and pro-inflammatory gene expression as well as CYP2E1 levels and activity 
were synergistically induced by alcohol and steatosis. CYP2E1 inhibition blunted these 
synergistic pathological effects. Notably, alcohol and cellular steatosis also induced 
autophagy in a synergistic manner, and also this was mediated via CYP2E1. Further 
induction of autophagy ameliorated the joint effects of alcohol and oleic acid on 
hepatocellular lipid accumulation and inflammatory gene expression while inhibition 
of autophagy further enhanced the dual pathological effects. Further analyses 
revealed that the joint synergistic effect of alcohol and steatosis on autophagy was 
mediated via activation of the JNK-pathway. In summary, our data indicate that 
alcohol induces not only pathological but also protective mechanisms in steatotic 
hepatocytes via CYP2E1. These findings may have important implications on the 
prognosis and treatment of alcoholic liver disease particularly in obese individuals. 
INTRODUCTION
Chronic alcohol consumption is one of the main 
etiological factors for liver disease worldwide; however, 
only a fraction of drinkers develop significant hepatic 
inflammation known as alcoholic steatohepatitis (ASH), 
and even less progress to significant hepatic fibrosis 
and cirrhosis. Still, alcoholic liver disease (ALD) is the 
second most common reason for liver transplantation in 
the United States and Europe, which clearly indicates the 
need to unravel the mechanisms and factors promoting 
hepatic injury in ALD [1, 2].
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More recently, the pathophysiological significance 
of hepatic lipid accumulation in the absence of significant 
alcohol consumption is increasingly recognized. Thus, 
nonalcoholic fatty liver disease (NAFLD) is now consider 
ed the most common cause of liver enzyme elevations in 
Western countries [3]. NAFLD is regarded as the hepatic 
manifestation of the metabolic syndrome, characterized by 
central obesity and insulin resistance, resulting in diabetes 
type 2, dyslipidemia, and hypertension [4]. Similarly to 
ALD, NAFLD encompasses a wide range of pathological 
conditions from mild hepatic steatosis to steatohepatitis 
(nonalcoholic steatohepatitis [NASH]) with significant 
necroinflammation and progressive fibrosis. In its 
advanced form, NASH is believed to account for a large 
fraction, if not entirely for what was previously termed 
“cryptogenic cirrhosis” [5]. 
Several studies suggest that hepatic steatosis alone 
can prime the liver to progress to more serious pathologies 
upon its exposure to subsequent metabolic stressors such 
as alcohol [6, 7]. Carmiel-Haggai et al. showed that short-
term binge alcohol exposure increased apoptosis and 
liver injury in obese rats compared to lean controls [8]. 
Recently, we have shown that chronic alcohol application 
in combination with a high fat diet significantly enhanced 
hepatic inflammation and fibrosis compared to alcohol 
or high fat diet alone [9]. Also clinical studies suggest a 
strong causative link between alcohol consumption and 
progressive liver disease in individuals with high fat-intake 
or obesity. Obese alcoholics have an accentuated elevation 
in serum transaminase levels [10, 11]. Furthermore, in 
subjects with heavy alcohol consumption, obesity is an 
independent risk factor for the development of both acute 
alcohol-induced hepatitis and cirrhosis [12, 13]. Even 
moderate alcohol consumption leads to an increase of 
liver enzymes with rising body mass index (BMI) [14]. 
Moreover, both elevated BMI and alcohol consumption 
are related to the progression of chronic liver disease, 
with evidence of a synergistic interaction between the two 
factors [15]. 
Alcohol as well as dietary lipids are predominantly 
metabolized in hepatocytes, rendering the interactions 
between alcohol- and lipid-metabolism very likely. 
Alcohol undergoes enzymatically-catalyzed oxidative 
metabolism to acetaldehyde by alcohol dehydrogenase 
(ADH) and microsomal cytochrome P450 CYP2E1. 
The resulting acetaldehyde is further oxidized by 
acetaldehyde dehydrogenase (ALDH) to acetate which 
leads ultimately to lipid accumulation, reactive oxygen 
species (ROS) formation and induction of oxidative stress 
[16]. On the other hand, hepatocellular lipid accumulation 
impairs the oxidative capacity of mitochondria and 
stimulates peroxisomal and microsomal pathways of 
fat oxidation, leading to additional oxidative stress that 
triggers production of inflammatory cytokines [17, 18]. 
However, it is incompletely understood how alcohol and 
obesity interact and whether the combined effects on the 
progression of liver injury are additive or synergistic.
The present study aimed to establish an in vitro 
model to study the effect of moderate alcohol levels on 
steatotic hepatocytes and to unravel the interacting effects 
between hepatocellular lipid accumulation and alcohol 
metabolism.
RESULTS
Effects of alcohol and oleic acid on hepatocellular 
lipid synthesis and accumulation
To study the combined effect of alcohol and oleic 
acid (oleate) on PHH, we chose an oleate concentration of 
0.2 mM and an alcohol (Alc) concentration of 50 mM. We 
have previous shown that hepatocellular steatosis induced 
by this oleate concentration led to pathological alterations 
similar to those found in hepatic tissue of NAFLD-
patients [19, 20]. Furthermore, previous in vitro studies 
have revealed that in vitro exposure of hepatic cells to 50 
mM alcohol mimics the situation of “moderate” alcohol 
consumption in humans [21-23]. In these concentrations, 
neither oleate or alcohol alone nor the alcohol and 
oleate combination affected the viability of PHH in vitro 
within 48h (Suppl.Figure S1A-C). Analysis of cellular 
triglyceride (TG) levels and oil red O staining showed 
that alcohol as well as oleate induced lipid accumulation 
in PHH (Figure 1A, 1B). Interestingly, the oleate and 
alcohol combination led to a significantly higher lipid 
accumulation in PHH than either of the two stimuli alone 
(Figure 1A, 1B). 
In search for the underlying mechanisms of this 
synergistic effect of alcohol and oleate we analyzed 
the expression of fatty acid synthase (FASN) the key 
enzyme of hepatic de novo lipogenesis. Alcohol or oleate 
alone had slight effects on FASN mRNA levels but the 
alcohol/oleate combination significantly enhanced FASN 
expression in PHH (Figure 1C). Similarly, alcohol and 
oleate synergistically up-regulated the gene expression 
of stearoyl-CoA desaturase-1 (SCD-1), which catalyzes 
a rate-limiting step in the synthesis of unsaturated fatty 
acids, and diglyceride acyltransferase (DGAT) 1 and 2, 
which catalyze the final step in triglyceride formation 
from diacylglycerol and Acyl-CoA (Figure 1D, 1E and 
Suppl.Figure S2). Together, these data show a synergistic 
effect of oleate and alcohol stimulation on lipogenesis and 
cellular lipid accumulation in PHH in vitro.
Oncotarget41466www.impactjournals.com/oncotarget
Effects of alcohol and oleate on hepatocellular 
lipid peroxidation and pro-inflammatory gene 
expression
In addition to lipid storage, enhanced lipogenesis 
can induce lipid combustion. Incubation with alcohol 
or oleate alone had only slight effects on the gene 
expression of carnitine palmitoyltransferase I (CPT1) 
and acyl-coenzyme A oxidase 1 (ACOX1), the key 
enzymes of the mitochondrial and peroxisomal beta-
oxidation systems, respectively (Figure 2A). However, 
the combination significantly enhanced CPT1 and ACOX1 
expression (Figure 2A) suggesting an increased oxidation 
rate of alcohol and free fatty acids, and consequently, 
an increased formation of reactive oxygen species 
(ROS) [24]. Accordingly, thiobarbituric acid reactive 
substance (TBARS) assay revealed a marked increase of 
malondialdehyde (MDA) levels in PHH stimulated with 
both alcohol and oleate while alcohol or oleate alone 
Figure 1: Analysis of the effect of alcohol and oleate on hepatocellular lipid metabolism and lipid accumulation. PHH 
were pre-incubated with 0.2 mM oleate (Ol) or BSA (served as control [Ctrl]) for 24h. Subsequently, cells were co-incubated with 50 mM 
alcohol (Alc) for additional 24h. A. Cellular triglyceride content normalized to total cellular protein. B. Representative images of cells 
stained with Oil red O (left panel); quantification of staining intensity of lipid droplets using a light microscope with digitalized camera 
and a Metaview image analysis system. The density of lipid droplets per microscopic area was calculated from four different fields (right 
panel). Analysis of mRNA levels of C. FASN, D. SCD-1 and E. DGAT2 by quantitative RT-PCR (*: p < 0.05 compared to control; #: p < 
0.05 compared to oleate or alcohol condition).
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had no or only slight effects on cellular MDA levels 
(Figure 2B). Also the expression of heme oxygenase-1 
(HMOX-1) and NADPH oxidase component p47phox 
was only significantly enhanced in PHH stimulated with 
the alcohol and oleate combination indicating increased 
cellular oxidative stress (Figure 2C). Oxidative stress is 
a known inducer of the transcription factor NFκB, which 
plays a critical role in the pathogenesis of both ALD and 
NAFLD [25]. NFκB is held inactive in the cytoplasm 
by its inhibitor IκBα, which exerts its inhibitory effect 
primarily through the interaction with p65, a subunit of 
NFκB complex, while phosphorylation of IκBα leads 
to its degradation, and subsequently, NFκB activation. 
The transcriptional activity of NFκB is controlled by 
phosphorylation of p65 at multiple serine residues. 
In our in vitro model, we observed enhanced phospo-
IκBα and phospho-p65 levels in alcohol or oleate 
stimulated PHH indicative of activation of the NFκB 
pathway. Interestingly, phospo-IκBα and phospho-p65 
levels were further enhanced by combined stimulation 
with both stimuli (Figure 2D). Interleukin-8 (IL-8) and 
intercellular adhesion molecule 1 (ICAM-1) are two 
pro-inflammatory genes which are regulated by NFκB 
and which correlate with hepatic inflammation in ALD 
and NAFLD [26, 27]. Notably, expression levels of 
IL-8 and ICAM-1 corresponded with phospo-IκBα and 
phospho-p65 levels in PHH stimulated with alcohol, oleate 
or their combination (Figure 2E). These findings indicate 
synergistic effects of oleate and alcohol on oxidative stress 
and pro-inflammatory gene expression in PHH in vitro.
Figure 2: Analysis of the effect of alcohol and oleate on lipid peroxidation and pro-inflammatory gene expression. PHH 
were pre-incubated with 0.2mM oleate (Ol) or BSA (served as control [Ctrl]) for 24h. Subsequently, cells were co-incubated with 50mM 
alcohol (Alc) for additional 24h. A. Analysis of cellular mRNA levels of CPT-1 and Acox-1 by quantitative RT- PCR. B. Analysis of cellular 
MDA levels by TBARS assay. C. Analysis of HMOX-1 and p47phox mRNA levels by quantitative RT-PCR. D. Analysis of p-IκBα and 
p-p65 phosphorylation by Western blot analysis. Actin served as control for loading adjustment. E. Analysis of IL-8 and ICAM-1 mRNA 
levels by quantitative RT-PCR. (*: p < 0.05 compared to control; #: p < 0.05 compared to oleate or alcohol condition).
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Role of CYP2E1 in joint effects of alcohol and 
oleate on hepatocellular lipid metabolism and 
pro-inflammatory gene expression
Ethanol metabolism by CYP2E1 leads to the 
generation of ROS which promote ethanol hepatotoxicity 
[28]. Furthermore, CYP2E1 carries out omega 
hydroxylation of fatty acids, and plays a critical role in the 
development and progression of NASH [29].
In our in vitro system, alcohol or oleate alone only 
slightly increased CYP2E1 mRNA and protein expression 
but the combination significantly induced CYP2E1 levels 
compared to control cells (Figure 3A). Similar results 
were observed by measuring the CYP2E1 activity using 
p-nitrophenol as specific CYP2E1 substrate (Figure 3B).
Figure 3: Analysis of the role of CYP2E1 in the effects of alcohol and oleate on hepatocellular lipid metabolism and 
pro-inflammatory gene expression. PHH were pre-incubated with 0.2 mM oleate (Ol) or BSA (served as control [Ctrl]) for 24h. 
Subsequently, cells were co-incubated with 50mM alcohol (Alc) for additional 24h. A. Analysis of cellular CYP2E1 levels by quantitative 
RT-PCR (right panel) and Western blot analysis (left panel). B. Analysis of CYP2E1 activity. HepG2 E47 cells which express CYP2E1 
and HepG2 C34 cells which do not express CYP2E1 were pre-incubated with 0.2 mM oleate (Ol) or BSA (served as control) for 24h. 
Subsequently, cells were co-incubated with 50 mM alcohol (Alc) for additional 24h. C. Cellular triglyceride content normalized to total 
cellular protein. D. Analysis of cellular MDA levels by TBARS assay. E. Analysis of cellular mRNA levels of FASN, F. CPT-1 G. HMOX1 
and H. ICAM-1 by quantitative RT-PCR. (*: p < 0.05 compared to corresponding control, #: p < 0.05 compared to corresponding OL or 
alcohol condition).
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To study the role of CYP2E1 in joint effects of 
alcohol and oleate, we compared hepatoma HepG2 cells 
expressing CYP2E1 (E47 cells) with HepG2 control cells 
(C34; not expressing CYP2E1) [30]. In E47 cells but not 
in C34 cells, combined effects of alcohol and oleate on 
cellular TG accumulation (Figure 3C), lipid peroxidation 
(Figure 3D) and gene expression of key enzymes of lipid 
metabolism (Figure 3E, 3F and Suppl.Figure S3A, B) and 
markers of oxidative stress (Figure 3G and Suppl.Figure 
S3C) and inflammation (Figure 3H) were significantly 
stronger than effects of alcohol or oleate alone. 
To verify the central role of CYP2E1 and ROS-
formation in our model, HepG2 E47 cells were incubated 
with chlormethiazole (CMZ), a CYP2E1 inhibitor, or 
Figure 4: Analysis the effect of inhibition of CYP2E1 activity or ROS production on the effects of alcohol and oleate 
on hepatocellular lipid metabolism and pro-inflammatory gene expression. HepG2 E47 cells were pre-incubated with 0.2mM 
oleate (Ol) or BSA (served as control) for 24 h. Subsequently, cells were co-incubated with chlormethiazole (CMZ; 100µM) or N-acetyl 
cysteine (NAC; 0.2mM) for 1h before adding 50mM alcohol (Alc) to cultured medium for additional 24h. A. Analysis of cellular mRNA 
levels of p47phox B. ICAM-1C. FASN and D. CPT-1 by quantitative RT-PCR. E. Cellular triglyceride content normalized to total cellular 
protein. F. Analysis of cellular MDA levels by TBARS assay. (*: p < 0.05 compared to corresponding control, #: p < 0.05 compared to 
corresponding oleate or alcohol condition).
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N-acetyl cysteine (NAC), a ROS scavenger. Both CMZ 
and NAC inhibited individual as well as combined effects 
of alcohol and oleate on markers of oxidative stress 
(Figure 4A and Suppl.Figure S4A) and inflammation 
(Figure 4B). Also alcohol and oleate effects on FASN, 
SCD-1 and DGAT1/2 expression were almost completely 
blunted by CMZ and NAC (Figure 4C and Suppl.Figure 
S4B). Furthermore, CMZ and NAC inhibited both 
individual alcohol effects and joint alcohol/oleate effects 
on CPT-1 expression (Figure 4D) and cellular TG and 
MDA levels (Figure 4E, 4F). In contrast, individual effects 
of oleate on cellular lipid levels, beta-oxidation and lipid 
peroxidation markers were not affected by CMZ or NAC 
(Figure 4D-4F). According CMZ and NAC effects were 
observed in primary human hepatocytes (Suppl.Figure 
S5). Together, these data indicate that CYP2E1 and ROS-
formation account for the synergistic effects of alcohol and 
oleate on cellular lipid accumulation, lipid peroxidation 
and pro-inflammatory gene expression. 
Effect of alcohol and oleate on the activation of 
autophagy
To get further insight into the joint effects of alcohol 
and oleate in hepatocytes, we focused on autophagy 
which is increasingly recognized as critical factor in the 
pathogenesis of both ALD and NAFLD [31, 32]. First, we 
investigated the effect of alcohol and oleate on the cleavage 
of the microtubule-associated 1 light chain 3 (LC3-I). The 
lipidation of LC3-I with phosphatidylethanolamine (PE) 
leads to the formation of LC3-II, which is a critical step in 
autophagosome formation and which can be visualized by 
western blotting where LC3-II appears as faster migrating 
band than LC3-I. Oleate or alcohol alone did not affect 
LC3-II levels but the Alc/OL combination significantly 
increased LC3-II expression in PHH compared to control 
cells (Figure 5A). 
The increased LC3-II levels can be associated 
with either PE conjugation due to enhanced formation 
of autophagosomes or a block of LC3-II degradation 
due to impaired maturation of autophagosomes. To 
distinguish between these two possibilities, we detected 
expression levels of sequestome 1 (p62), a protein that is 
degraded by autophagy and accumulates when autophagy 
is impaired. As shown in Figure (Figure 5B), alcohol/
oleate combination led to a significant decrease in p62 
protein levels, which indicates increased autophagy. 
Pre-incubation with chloroquine (CQ) (which raises the 
lysosomal pH leading to inhibition of both fusion of 
autophagosome with lysosome and lysosomal protein 
degradation) caused a time-dependent increase of the 
LC3II/LC3I in response to stimulation with the alcohol/
oleate combination in comparison to alcohol or oleate 
alone (Figure 5C). This indicates that the combination 
is causing an increased autophagic flux rather than an 
increase of the lysosomal activity. To assess the dynamic 
of the autophagic flux, we performed time course 
experiments and found that the alcohol/oleate combination 
started to induce LC3 II/I ratio after 6h. This increase 
became significant after 12h and continued to rise up to 
24h (Suppl.Figure S6A). The raise in LC3 II/I ratio was 
accompanied with a concomitant reduction in p62 protein 
levels (data not shown).
Fitting to this, expression of the critical autophagy-
related genes ATG7 and ATG12 (Figure 5D and Suppl.
Figure S6B) as well as the pro-autophagic kinase vacuolar 
protein sorting 34 (VPS34) (Figure 5E) was not or 
only slightly increased in PHH after alcohol or oleate 
stimulation while alcohol/oleate caused a marked increase. 
Very similar effects were observed in CYP2E1 expressing 
E47 cells, while neither alcohol or oleate alone nor their 
combination significantly affected ATG7, ATG12 or 
VPS34 expression in C34 cells lacking CYP2E1 (Figure 
5F and Suppl.Figure S6C). Also CMZ and NAC blunted 
the joint effect of alcohol and oleate on pro-autophagic 
gene expression (Figure 5G and Suppl.Figure S6D). 
Together, these findings suggest that joint effects of 
alcohol and oleate on CYP2E1 and ROS formation cause 
an induction of autophagy.
Role of autophagy in the synergistic effects of 
alcohol and oleate on lipid accumulation, lipid 
peroxidation and hepatocellular inflammation
To assess the functional role of autophagy in 
synergistic alcohol and oleate mediated effects, HepG2 
E47 cells were pre-incubated with 3-methyl adenine (3-
MA), a highly specific inhibitor of VPS34. 3-MA treatment 
enhanced basal alcohol- and oleate-induced triglyceride 
accumulation (Figure 6A), MDA levels (Figure 6B) and 
ICAM-1 expression (Figure 6C). Moreover, 3-MA further 
enhanced the effect of the alcohol/oleate combination on 
the expression of the pro-inflammatory gene ICAM-1 
(Figure 6C). Similarly, chloroquine treatment significantly 
aggravated the effects of alcohol and oleate alone as 
well as their combination on the expression of oxidative 
stress markers and pro-inflammatory genes (Supp.Figure 
S8). Conversely, stimulation with the autophagy inducer 
rapamycin slightly inhibited alcohol and oleate effects on 
these parameters (Figure 6D-6F). Especially, joint effects 
of alcohol and oleate on triglyceride, MDA and ICAM-
1 mRNA levels were completely blocked by rapamycin 
(Figure 6D-6F). These findings could be confirmed in 
PHH (Suppl.Figure S7A, B). Together, these data indicate 
that autophagy inhibits combined alcohol and oleate 
mediated effects on hepatocellular lipid-accumulation, 
lipid-combustion and pro-inflammatory gene expression.
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Figure 5: Analysis of the effect of alcohol and oleate on the activation of autophagy. PHH or HepG2 E47 cells were pre-
incubated with 0.2mM oleate (Ol) or BSA (served as control) for 24h. Subsequently, cells were co-incubated with/without chloroquine 
[CQ] (10 µM) for 1 h before adding 50 mM alcohol (Alc) to cultured medium for additional 24h. A. Analysis of LC3I/II protein levels 
in PHH by Western blot analysis (left panel); densitometric analysis of LC3II/I ratio of 3 experiments (right panel). B. Analysis of p62 
protein expression in PHH by Western blot analysis (upper panel); densitometric analysis of p62 protein of 3 experiments (lower panel). 
C. Analysis of LC3I/II protein levels in HepG2 E47 cells by Western blot analysis. D. Analysis of ATG7 mRNA and protein levels in PHH 
by quantitative RT-PCR and Western blot analysis. Actin served as control for loading adjustment. E. Analysis of cellular mRNA levels 
of VPS34 in PHH by quantitative RT-PCR. F. Analysis of cellular mRNA levels of ATG7 and VPS34 by quantitative RT-PCR in HepG2 
C34 (not expressing CYP2E1) in comparison with HepG2 E47 cells (expressing CYP2E1). G. Analysis of cellular mRNA levels of ATG7 
and VPS34 by quantitative RT-PCR in HepG2 E47 cells (Ctrl cells) in comparison to chlormethiazole (CMZ) or N-acetylcysteine (NAC)-
treated cells. (*: p < 0.05 compared to corresponding control; #: p < 0.05 compared to corresponding oleate or alcohol condition).
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Figure 6: Analysis the effect of autophagy inhibition or induction on the effects of alcohol and oleate on lipid 
accumulation, lipid peroxidation and inflammation. HepG2 E47 cells were pre-incubated with 0.2mM oleate (Ol) or BSA (served 
as control) for 24h. Subsequently, cells were co-incubated with 3-methyl adenine (3-MA), an autophagy inhibitor (2.5mM) or rapamycin 
(0.2µg/ml) for 1 h before adding 50mM alcohol (Alc) to cultured medium for additional 24 h. A., D. Cellular triglyceride content normalized 
to total cellular protein.  B., E. Analysis of cellular MDA levels by TBARS assay. C., F. Analysis of ICAM-1 mRNA levels by quantitative 
RT-PCR analysis. (*: p < 0.05 compared to corresponding control; #: p < 0.05 compared to corresponding oleate or alcohol condition; $: p 
< 0.05 compared to the equal condition in control group).
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The role of JNK pathway in the synergistic effects 
of alcohol and oleate on autophagy activation
In search for the mechanism, by which alcohol and 
oleate jointly affect autophagy, we analyzed the effects 
of these stimuli on the activation of c-Jun N-terminal 
kinase (JNK) because recent studies found that JNK can 
mediate the induction of autophagy in hepatic as well as 
non-hepatic cells [33-35]. Moreover, increasing oxidative 
stress by alcohol can activate the JNK-signaling pathway 
in CYP2E1-dependent manner, and also free fatty acids 
have been shown to induce autophagy in hepatocytes via 
JNK activation [34, 36, 37]. In our experimental model, 
stimulation with alcohol or oleate alone exhibited no or 
only slight effects on phopsho-JNK and phospho-c-JUN 
protein levels in PHH while the combination caused a 
significant increase of JNK and c-JUN phosphorylation 
(Figure 7A). Neither alone nor in combination alcohol 
and oleate affected the total JNK expression levels (Figure 
7A). Pre-incubation with the specific JNK inhibitor 
(SB600125) abrogated the alcohol- and oleate-induced 
increase of LC3-II levels as well as the reduction in p62 
protein levels in hepatocytes (Figure 7B). Moreover, JNK 
inhibition blocked the alcohol/oleate-induced ATG7 and 
ATG12 up-regulation (Figure 7C, 7D). Together, these 
findings indicate that the joint effects of alcohol and 
oleate on autophagy in hepatocytes are induced via JNK-
activation.
DISCUSSION
In this study, we developed a new in vitro model 
to study the effects of moderate, non-toxic alcohol levels 
on lipid-loaded and control hepatocytes and unraveled 
interacting, synergistic effects between hepatocellular lipid 
accumulation and alcohol metabolism. 
Circulating free fatty acids (FFA) are also the 
major mediators of excessive hepatic lipid accumulation 
in patients with NAFLD. The rate of hepatic FFA uptake 
is not regulated, and therefore, is proportional to plasma 
FFA concentrations [38]. In NAFLD patients, circulating 
FFA are commonly elevated, and their plasma levels 
correlate with disease severity [39]. Already previously, 
we had established an in vitro model of cellular lipid 
accumulation in PHH and HepG2 cells and confirmed 
that the pathological mechanisms observed in this model 
system closely mimic the pathological alterations found in 
hepatic tissue of NAFLD-patients [19, 20, 40].
In the present study, we combined this model with 
alcohol stimulation. Also alcohol is known to induce 
hepatocellular lipid accumulation in vitro and in vivo 
[23, 41]. Alcohol oxidation leads to acetyl-CoA synthesis 
from acetate or citrate that constitutes the substrates 
for lipogenic enzymes, and accordingly, we observed 
an increased expression of FASN and SCD1 in alcohol 
stimulated PHH. Also stimulation with oleate caused 
an increase in the expression of both enzymes but this 
induction was significantly stronger in combination 
with alcohol. Similarly, the induction of triglyceride 
synthesis and cellular triglyceride levels were moderate 
upon stimulation with alcohol or oleate compared to the 
combination of both stimuli. Similar joint effects were 
observed on the expression of key enzymes of lipid 
oxidation, which are known to cause ROS formation. 
Accordingly, also gene expression indicative for oxidative 
stress and cellular malondialdehyde (MDA) levels were 
markedly increased by alcohol in combination with 
oleate stimulation while either of the two stimuli alone 
exhibited no or only slight effects. Moreover, we found 
that alcohol and oleate combination induced significantly 
more pro-inflammatory activity in hepatocytes than either 
of the two stimuli alone. Previous studies have found that 
effects of free fatty acids on hepatocytes may dependent 
on their degree of saturation [42, 43]. In the present study 
we mainly applied the unsaturated fatty acid oleate to 
induce hepatocellular lipid accumulation because we have 
previously shown that the oleate induced in vitro steatosis 
causes cellular alterations similar to those found in hepatic 
tissue of NAFLD-patients [19, 20]. However, we also 
analyzed the combined effects of alcohol and the saturated 
fatty acid palmitate on the expression of genes that affect 
ß-oxidation, autophagy and inflammation and found 
similar effects as observed by alcohol in combination with 
oleate (Suppl.Figure S9). 
Noteworthy, joint effects of alcohol and oleate on 
cellular lipid accumulation and pro-inflammatory gene 
expression were dependent on CYP2E1 activity. CYP2E1 
activity has been shown to correlate with alcohol-induced 
liver injury, and inhibition of CYP2E1 prevented the 
induction of hepatic steatosis and ROS production in 
models of alcoholic steatohepatitis [23, 41, 44]. Also in 
NASH, increased CYP2E1 activity has been described 
and has been identified as a pathogenic factor [45-47]. 
Interestingly, in our in vitro model we found that the 
combination of alcohol and oleate induced CYP2E1 levels 
and its activity significantly more than each stimulus 
alone. Moreover, CYP2E1 inhibition had only slight 
effects on hepatocellular lipid accumulation and MDA 
formation induced by singly alcohol or oleate stimulation, 
respectively. In contrast, joint effects of alcohol and 
oleate on hepatic steatosis and lipid peroxidation were 
completely blunted. These effects indicate a crucial 
role of CYP2E1 and subsequent ROS production in the 
underlying pathophysiological mechanism of synergistic 
effects of alcohol and oleate.
Autophagy, a highly conserved intracellular 
catabolic pathway for the degradation of long-lived 
proteins and cytoplasmic organelles, can either be 
increased or decreased by ethanol depending on the used 
model, the dose, the evaluated tissue and the experimental 
conditions [48] . While the effects of ethanol on autophagy 
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Figure 7: Analysis the role of JNK pathway in the synergistic effects of alcohol and oleate on autophagy activation. 
PHH or HepG2 cells were pre-incubated with 0.2 mM oleate (Ol) or BSA (served as control) for 24 h. Subsequently, cells were co-
incubated with 50 mM alcohol (Alc) for additional 24 h. A. Analysis of p-JNK, total JNK and p-c-JUN protein levels in PHH by Western 
blot analysis (left panel); densitometric analysis of p-JNK/ total JNK ratio of 3 experiments (right panel). Actin served as control for loading 
adjustment. HepG2 E47 cells were pre-incubated with 0.2mM oleate (Ol) or BSA (served as control) for 24h. Subsequently, cells were co-
incubated with JNK inhibitor (10µM) for 1 h before adding 50mM alcohol (Alc) to cultured medium for additional 24h. B. Analysis of LC3 
I/II proteins and p62 protein levels by Western blot analysis (left panel); densitometric analysis of LC3II/LC3 I ratio (right upper panel) and 
p62 level (right lower panel) of 3 experiments (right panel). Actin served as control for loading adjustment. C. Analysis of cellular mRNA 
levels of ATG7 and ATG12 by quantitative RT-PCR. (*: p < 0.05 compared to corresponding control; #: p < 0.05 compared to corresponding 
oleate or alcohol condition).
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are complex and require further study, it is becoming 
clear that autophagy serves a protective function against 
ethanol-induced liver injury [31]. Moreover, induction of 
autophagy has been shown to alleviated hepatic steatosis 
and injury in models of acute and chronic ethanol exposure 
[23, 31, 36, 49]. Of note, ethanol-induced autophagy 
requires its metabolism via CYP2E1 and subsequent ROS 
production [23, 36, 50]. Moreover, blocking CYP2E1 or 
inhibiting ROS by antioxidants also diminished GFP-
LC3 puncta [23, 36, 50]. It seems that alcohol oxidation 
by CYP2E1 is also important for alcohol-induced 
inhibition of cellular proteasome activity and increased 
autophagosome numbers [51]. 
In our in vitro model, which mimics moderate 
alcohol exposure and FFA-induced steatosis, neither 
alcohol nor oleate alone caused a significant induction of 
autophagy markers in hepatocytes. In contrast, the alcohol/
oleate combination led to a marked up-regulation of the 
autophagic flux, and we revealed that this synergistic effect 
on autophagy was mediated via JNK-activation. Inhibition 
of autophagy induced lipid accumulation, oxidative 
stress and inflammation, while induction of autophagy 
alleviated these mechanisms. Still, it appears that under 
the experimental conditions used, autophagy could not 
counterbalance the negative effects in this in vitro model. 
One may speculate that also in vivo there is a fine balance 
between protective and damaging mechanisms. Only 
slight differences in the ratio of individual beneficial and 
detrimental factors may decide whether moderate alcohol 
consumption is protective or is causing harm in (non-
alcoholic) fatty livers. Actually, there are some studies 
assuming that moderate alcohol consumption might 
even be protective for patients with NAFLD [52, 53]. It 
is intriguing to speculate whether intensified effects of 
alcohol on autophagy in steatotic hepatocytes may (in 
part) account for such observations. 
Of note, the joint effect of alcohol and cellular 
steatosis on autophagy required CYP2E1 activity in 
our in vitro model. Generally, this cytochrome P450 is 
known for its detrimental effects in alcoholic liver disease 
through free radical formation and lipid peroxidation [23, 
54]. Therefore, pharmacological inhibition of CYP2E1 
has emerged as strategy for treatment of alcohol-induced 
liver injury [54, 55]. Also in our in vitro system, CYP2E1 
accounts for detrimental effects of alcohol in lipid loaded 
hepatocytes, and certainly, the clinical relevancy of our 
in vitro findings has to be verified. Still, the CYP2E1 
mediated joint effect of alcohol- and oleate-induced 
steatosis on autophagy indicate that the manipulation of 
CYP2E1 may be a double-edged sword and warrant the 
exercise of caution in the pharmacological use of CYP2E1 
inhibitors for the treatment of alcoholic liver disease in 
obese individuals. Furthermore, one may speculate 
whether individual factors tipping the balance on the one 
or the other side of detrimental or beneficial joint effects 
of alcohol and free fatty acids account at least in part for 
the high variation in the clinical course of alcoholic liver 
disease. 
In summary, in our in vitro model, exposure 
of hepatocytes to alcohol and the fatty acid oleate 
caused a synergistic effect on lipid accumulation, lipid 
peroxidation, oxidative stress and inflammatory gene 
expression. Conversely, alcohol and oleate jointly induced 
autophagy which reduced these pathological mechanisms. 
Noteworthy, both detrimental as well as beneficial joint 
effect of alcohol and FFA were dependent on CYP2E1 
activity. Upon clinical verification these in vitro findings 
may have important implications on the prognosis or 
treatment of alcoholic liver disease.
MATERIALS AND METHODS
Cells and cell culture model
Isolation and culture of primary human hepatocytes 
(PHH) were performed as described [56]. Human liver 
tissue for cell isolation was obtained from the charitable 
state controlled foundation HTCR, with informed patient 
consent and approved by the local Ethics Committee. 
HepG2 E47 cells which express CYP2E1 and 
HepG2 C34 cells which do not express CYP2E1 were 
cultured as described [30].
PHH or HepG2 cells were incubated with oleate 
(Ol) (doses up to 0.2 mM) for 24 h as described [20]. 
We have previously shown that this treatment leads to 
cellular steatosis and pathological alterations similar to 
those found in hepatic tissue of NAFLD-patients [19, 20, 
40]. Subsequently, cells were co-incubated with clinically 
relevant non-toxic concentration of alcohol (Alc) (up to 
50 mM) [21-23] for 16-24 h. In additional experimental 
conditions, cells were treated with 3-methyl adenine (3-
MA; 2.5 mM), rapamycin (0.2 µg/ml), chlormethiazole 
(CMZ; 100 µM), N-acetyl cysteine (NAC; 0.2 mM), JNK 
inhibitor (SB600125; 10 µM) or chloroquine (CQ; 10 µM) 
for 1 h before adding alcohol to the cell cultured medium. 
All experiments have been repeated at least three times.
Mitochondrial activity assay
For quantification of hepatocellular mitochondrial 
activity, the colorimetric XTT assay (Roche Diagnostics, 
Mannheim, Germany) was used according to the 
manufacturer’s instructions. 
Analysis of CYP2E1 activity
Hepatocytes were washed twice, incubated with 0.2 
mM p-nitrophenol at 37°C for 2h, and then the reaction 
was terminated by adding trichloroacetic acid to a final 
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concentration of 1% (v/v). Cells were harvested and 
centrifuged at 5,000g for 5 min, and the supernatants were 
assayed for 4-nitrocatechol by adding NaOH to a final 
concentration of (1N) and immediately determining the 
absorbance at 492 nm.
Analysis of cellular lipid content
Cellular lipid droplets were visualized by Oil Red 
O staining as described [20]. Lipid droplets were assessed 
using a light microscope with digitalized camera and 
a Metaview image analysis system (Olympus America 
Inc., PA). The density of lipid droplets per microscopic 
area was calculated from four different fields. Total 
cellular triglycerides were extracted and quantified by the 
triglyceride determination kit (GPO) (Sigma, Deisenhofen, 
Germany) as described [20].
Analysis of lipid peroxidation
Cellular malondialdehyde (MDA) levels were 
analyzed using the OxiSelect-thiobarbituric acid-reactive 
substance (TBARS) assay kit (Cell Biolabs, San Diego, 
CA, USA) following the manufacturer’s instructions. 
Quantitative real-time-PCR analysis
RNA isolation from cultured cells and reverse 
transcription were performed as described [57]. 
Quantitative real-time-PCR was performed applying 
LightCycler technology (Roche) [57] with specific sets of 
primers. Amplification of cDNA derived from 18s rRNA 
was used for normalization.
Protein analysis
Protein extraction and Western blotting was 
performed as described [58] applying anti-rabbit 
antibodies against phospho-IκBα (#2859), phospho-
NFκBα p65 (#3033), phospho-JNK (#9251), JNK (#9258), 
phospho-c-Jun (#3270), p62 (#5114) and ATG7 (#2631), 
all from Cell Signaling Technology (Danvers, MA, USA; 
all diluted 1:1,000). Furthermore, antibody against LC3 
(NB100-2220, Novus Biologicals, Cambridge, UK; 
1:1000) was applied.
Statistical analysis
Values are presented as mean ± SEM. Comparison 
between groups was made using the Student’s unpaired 
t-test. A p value <0.05 was considered statistically 
significant. All calculations were performed using the 
statistical computer package GraphPad Prism version 4.00 
for Windows (GraphPad Software, San Diego, USA).
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